Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, par value $0.001 per share · CUSIP: 252828108

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 2,981,674.00 · Class: 6.9%

  • Point72 Capital Advisors, Inc.

    Shares: 2,981,674.00 · Class: 6.9%

  • Steven A. Cohen

    Shares: 2,981,674.00 · Class: 6.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001155
Form type
SCHEDULE 13G/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub